Dr. Ben Collins
Our group was established in March 2016 at the Institute for Molecular Systems Biology, ETH Zurich, with the support of an SNF Ambizione grant (aimed at young researchers who wish to conduct, manage and lead an independent project at a Swiss higher education institution). The focus of this SNF Ambizione program is 'The host-pathogen protein interactome of Mycobacterium tuberculosis'.
Ben is a native of Ireland where he studied chemistry and applied chemistry at the National University or Ireland, Galway, for his bachelors degree. After working as an analytical chemist in Schering-Plough, Ireland, he undertook an MSc in Molecular Medicine at Trinity College Dublin. Ben's PhD entitled 'Mass Spectrometry-Based Proteomics to Support Pre-Clinical Pharmaceutical Toxicology Evaluation' was completed at University College Dublin in 2009 where he remained for 1 year as the Agilent Technologies Newman Fellow (postdoctoral) in Quantitative Proteomics. Ben moved to the Institute of Molecular Systems Biology at ETH Zurich in Autumn 2010 as postdoctoral researcher under the supervision of Prof. Ruedi Aebersold and Dr. Matthias Gstaiger, where his research focused on the application of quantitative interaction proteomics in signaling and the development of SWATH mass spectrometry. Now as a group leader Ben is focusing applying methods developed as a postdoc to relevant problems in host-pathogen biology with a focus on Mycobacterium tuberculosis.